BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
GATA1
,
Apoptosis
,
Diabetes mellitus
,
Hippocampus
,
Neocentromeres
,
Rapamycin
,
rs4950928
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CTACK
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Nipple cross-section
Skin
Basophil of peripheral blood
Cingulate cortex
Fetal thyroid
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Wound of skin
Injury of integument
Psoriasis
Eruption
Lichen
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Ceftazidime
Pyrimidinones
Fluvoxamine
Brodalumab
vaccinia-CEA vaccine
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
KCNIP3
EXOSC9
CHRNB2
NDE1
APLP2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
CCL27 Signaling in the Tumor Microenvironment.
Connexin26 Modulates Radiation-Induced Skin Damage by Regulating Chemokine CCL27 through MAPK Signal…
The CCL27-CCR10 axis contributes to promoting proliferation, migration, and invasion of lung squamou…
Cutaneous T-cell-attracting chemokine as a novel biomarker for predicting prognosis of idiopathic pu…
Roles of CCR10/CCL27-CCL28 axis in tumour development: mechanisms, diagnostic and therapeutic approa…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study to Assess Efficacy and Safety of XC221 200 mg in the Treatment of Influenza or Other ARVI
Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ